Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7,351 JPY | +0.26% | -0.66% | -24.97% |
Feb. 26 | Jefferies Adjusts GMO Payment’s Price Target to 11,000 Yen From 13,350 Yen, Keeps at Buy | MT |
2023 | Enpay Inc. announced that it has received ¥850 million in funding from a group of investors | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 33.62 and 26.92 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.97% | 3.47B | C | ||
+14.93% | 90.29B | B | ||
+10.60% | 70.52B | B | ||
-5.62% | 46.8B | C- | ||
-3.33% | 31.8B | C- | ||
+6.91% | 21.92B | C+ | ||
-17.88% | 12.08B | A- | ||
-11.16% | 10.1B | C | ||
+8.59% | 9.16B | C+ | ||
-26.03% | 7.86B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 3769 Stock
- Ratings GMO Payment Gateway, Inc.